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Abstract
According to the International Conference for Harmonization (ICH), the 
 validation and verification data must be included in the Electronic Common 
Technical Document. The validated analytical procedure gets automatically Food 
and drug approved (FDA) if it is part of New drug application (NDA), Abbreviated 
new drug application (ANDA) or Biologic license application (BLA). The analytical, 
bioanalytical and stability-indicating methods are essential part of all above said 
regulatory submissions. There are certain ways to generate these analytical methods 
like U.S. pharmacopeia/National Formulary which are Food and drug approved. 
The validated analytical method can also be submitted by any researcher or agency 
which can gets the food and drug approval. It is necessary that the methods which 
are Food and drug approved can only be applied to the various drugs and drugs 
products. In the current chapter, the meaning and requirements of analytical 
methods, procedures, acceptance criteria and evaluation of stability indicating 
methods, need, recommendations for bioanalytical methods are discussed in detail. 
The analytical techniques like HPTLC, HPLC, Spectrophotometry and Hyphenated 
techniques are also discussed as these are playing important role in validation of 
these methods.
Keywords: noncompendial and compendial analytical methods, forced degradation 
analytical techniques, bioanalytical methods, analytical techniques
1. Introduction
The United States of America (USA), Europe and Japan were developed the 
Common Technical Document (CTD) which should be implement while apply-
ing for registration of pharmaceutical product for human use. For the develop-
ment of these guidelines International conference for Harmonization (ICH) 
plays important role and currently these are becoming the part of ICH guidelines 
[1]. The identity, strength, quality, purity and potency are important points 
of Investigational new drug application (IND), New drug application (NDA), 
Abbreviated new drug application (ANDA). The related analytical methods of 
drug substance and product should be included in NDA and ANDA. A Complete 
description, total manufacturing process including analytical procedures should 
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ensure compliance with standards and potency should be part of Biologics license 
application (BLA). It is must to meet all standards of guidelines provided for 
analytical procedures. All these parameters should be suitable for their purpose 
wherever applicable. Detail Analytical procedures including detail validation 
parameters are the important part of Electronic Common Technical Document 
Specification as per International conference of Harmonization (ICH). The analyti-
cal procedure is Food and Drug Approved (FDA) if it a part of Approved NDA, 
ANDA or BLA. These methods can be generated from FDA recognized sources like 
U. S. Pharmacopeia/National Formulary (USP/NF) or if anyone submits validated 
procedure that will be accepted by FDA. The only validation or verification data of 
FDA approved methods of new products are considered for applications to various 
drug products (Figure 1).
Every manufacturer must generate large amount of corrected data for safety and 
efficacy of drug for commercial viewpoint. As it is mandatory to follow Current 
Good Manufacturing practices (cGMPs) for manufacturing purpose, likewise each 
analytical activity must follow Good Analytical Practices.
Method Validation, calibrated instrument, and training are three important 
tasks of Good analytical practices (GAPs). Commercially available dosage form is 
an outcome of several steps which are systematically carried out during product 
development. It is very important that all steps should be carried in systematic 
manner to ensure complete drug development stage. In recent years there is special 
focus on efficiency and efficacy of drug product and for this clinical study is most 
important task but apart from this there are various behind the scene activities 
are associated with drug development process without which pharmaceuti-
cal drug development is not possible. Among these behind the scene activities 
Method Development and Validation has its own uniqueness to ensure the drug 
development.
Figure 1. 
Flow chart showing essential requirements of registration of pharmaceutical product.
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2. Noncompendial analytical method validation
The objective and plan of work should be clearly defined prior to start the 
work. This data is based on scientific findings from the method development and 
Optimization. The validation of results should be obtained by approved protocol. 
Then sponsor must follow cGMP’s which includes detail procedure, validation charac-
teristics and acceptance criteria by the use of qualified instrumentation. All the proto-
cols of drug substance and product analytes in respective matrices should be prepared 
and followed. All the results of validation studies, application should be included.
3. Compendial analytical procedures
The analytical procedure official in pharmacopeias, are cross checked for imple-
mentation stage and its suitability should be checked. The verification protocol 
should include details of data which explains suitable analytical procedure official 
in USP/NF for drug product or drug substance.
The following points are to be included in the verification protocol
1. The compendia method which should be verified with acceptance criteria’s.
2. All parameters related to each aspect of method that is reagent, equipment, 
validation characteristics that is specificity, Limit of quantitation (LOQ ), 
Precision, accuracy, should be included in validation are covered by proce-
dure and extent of verification. There is no need to include robustness study 
for compendia assays if there is no deviation. For a BLA, if the methods are 
already specified in FDA regulations, there is must to take pre-approval from 
FDA to change in analytical method.
3.1 Statistical analysis
The statistical analysis is important work after finishing the method develop-
ment and validation. The statistical values of validation are compared with the 
predetermined acceptance criteria.
The statistical parameters used are based on proper principle and required for 
evaluation of parameter. The methods like analysis of variance (ANOVA) for analysis 
of regression analysis, (R2-Correlation coefficient) to measure the linearity are applied 
for studying validation characteristics. In case of observed data is not distributed then 
it is transformed normal distribution or distribution free approach. By using validates 
software or independent verification for correctness the data can be analyzed.
3.2 System suitability requirement for potency assay
Before starting actual analysis of standard sample, it is necessary to check 
whether system is working properly or not. This important task can be completed 
by analyzing system suitability. In this all integral system that is equipment, elec-
tronics, analytical operations and samples are evaluated. These system suitability 
parameters are depending on method or procedure under validation.
System suitability can be evaluated according to following points:
1. The system suitability measures the performance of given system of samples 
on a given day. 2. The variable parameters like chromatographic columns, col-
umn aging, mobile-phase variations, changes in instrumentation are checked 
whether they are working properly or not.
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2. It is nothing but the part of method validation. The experience and informa-
tion obtained at the time of method development, which is helpful to deter-
mine system suitability of final method.
3. At every time when system is used for performing the assay there is necessary 
to use system suitability test. For longer period if it is continuously in use then 
there is need to reevaluate the system suitability at proper intervals.
4. The system suitability means criteria and parameters obtained collectively 
which can explain the system are working properly [2].
The important aspects of pharmaceutical development program are analyti-
cal method development, validation method transfer but it is fact that they are 
less considered in sense of total contribution in development process, time and 
economy. At the time of drug development phases, all the analytical method related 
activities are interrelated. In early development stages they are related and occur 
one after another in coming phases of development. During drug development pro-
cess the changes may require to be performed in current methods and these changes 
in methods again requires validation or method transfer treatment.
If one’s objective of method development and validation is achieved, then it 
can prove that the laboratory facilities are accurate and fit for further develop-
ment process that is one can say optimized. Method validation is the “process of 
demonstrating that analytical procedures are suitable for their intended use.” Both 
method validation and methods transfer have important share in drug development 
and further changes in methods. To generate supportive data during manufactur-
ing and quality control, these methods provides a valuable data by comparing with 
specifications including all types stability study, Safety, characterization and drug 
performance can obtain with these supportive methods.
Method development is the simultaneous process as the gradual development of 
drug product continues. The system suitability parameters are set of tests to checks 
the proper working of the system. After performing robustness with proper statisti-
cal data collection one can set the criteria for final system suitability of the method.
These methods focus on active pharmaceutical ingredient (API) behavior. As 
the knowledge about API and drug product goes on progress the analytical methods 
become more refined. The important aspects of analytical method are that should 
be robust, simple and meeting the regulatory guidelines. Various trial an error 
experiments are to be carried out to develop the method. The performance criteri-
on’s to be finalized before the final validation of method. Forced degradation study 
which is integral part of stability-indicating method and system suitability tests are 
one of the key points of method development and final validation [3].
3.3 Impurity profiling
The International Conference for Harmonization (ICH) guidances are available 
that are related to the qualification of impurities in new drug substances that are 
produced by chemical synthesis. These impurities can be addressed in two perspec-
tives that are chemistry aspects and safety aspects. The chemistry aspects explain 
the identification and classification of impurities, the various analytical procedures 
and setting of specifications. In the safety aspects explains the qualification of 
impurities which are not addressed in clinical trials. In this aspect the threshold lim-
its are defined. This ICH guidance classifies impurities in three classes as Organic, 
Inorganic and Solvent. Each class of impurities should be properly reported, with 
all aspects, developed during synthesis, storage of the new drug product. The 
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analytical procedure including validation reports related to impurities should be 
properly reported [4]. In concern with the above discussed guidelines related to 
qualification of impurities in new drug substances produced by chemical synthesis, 
impurities which are classified as degradation product developed with the reac-
tion with excipients or container closure system may termed as reaction products. 
All the observed degradants during manufacturing and stability study should 
be reported. All the data related to their identification, specification, analytical 
procedures for quantification, their limits of detection and quantification should be 
reported [5].
4. Stability-indicating method
To ensure safety, efficacy and quality of drug product there are need of stability 
indicating methods. The Food and Drug Administration (FDA) defines the stability 
indicating method as a validated analytical procedure that accurate and precisely 
measure active ingredients (drug substance or drug product) free from process 
impurities, excipients and degradation products [6].
To obtain forced degraded samples for assessing selectivity of method, method 
development and method validation are three important steps of stability indicat-
ing methods.
4.1 Importance of forced degradation
As per guidance document available for stability indicating method does not 
contain any explanation about extent up to which the degradation should be carried 
out. There are no certain guidelines regarding stress degradation. Therefore, it is 
always necessary to keep all experimental conditions of degradation with more 
reality and deliberate degradation.
The main purpose of forced degradation is to obtain stability of drug. It should 
provide information about route of degradation and utility towards the stability 
indicating [6].
Forced degradation can be able to judge excipients or non-drug substances. It 
also provides information useful for structure elucidation of degradation products. 
Importantly it gives data related to thermal, hydrolysis, and oxidation and photo deg-
radation behavior of drug substance and drug product. It is very important to know 
about chemical behavior of drug product and drug substance in formulation devel-
opment, manufacturing and packaging. The data helps in quality improvement [7].
4.2 Acceptance criteria for forced degradation
There are vast discussions among the various scientists that what should be the 
limits of stress testing? Generally, values in between 5–20% are proper and accept-
able for chromatographic assays. The acceptable stability limit for small molecules 
are 90% of label claim and generally employed by pharmaceutical scientist that is 
10% degradation is optimum for use in analytical validation. There are some experi-
ments in which very little or no degradants are obtained due to exceptional stability 
of molecule under study in such case accelerated storage 400 c for 6 months should 
be carried out. If positive result is obtained, then the stability of drug is noted. But 
overstressing the drug substance may produce false results [7].
According to the recent recommendations of Food and Drug administra-
tion (FDA) and ICH guidelines, the stability indicating property of analytical 
method can be obtained by carrying out forced degradation study. The pathway 
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of decomposition from API, solution and formulation also be determined. The 
structural information, their characterization and isolation of major degradants are 
the important part of the new drug approval (NDA). The use of forced degradation 
study is primary to understand molecular chemistry of drugs, its stability indicating 
properties and its degradation products and their pathways. In most of the cases the 
Hydrolysis, Oxidation, Photolysis, Racemization, and Decarboxylation are the type 
of reactions that are responsible for decomposition of most the drugs. However, the 
regulatory guidelines do not define the procedures to carry out degradation study. 
Therefore, there are various approaches to carry out forced degradation study [8].
4.3 Stress conditions
In pharmaceutical industry thermal, hydrolysis, oxidation and photo degrada-
tion are generally employed. If one must serve the purpose of degradation, the 
expected degradation should be achieved. The optimum percentage of degradation 
should be obtained in all types of conditions or in minimum of one according to 
FDA guidelines. If no degradation is achieved, then in that case, all reports related 
degradation experiment carried out should be produced. It is important fact to 
obtain the degradation as per expected level. The degradation in between 5 and 20% 
is recommended [9].
4.4 Hydrolysis
By using acid and base the hydrolysis studies are performed. Generally, a chemi-
cal reaction is carried out with water to obtain decomposed analyte. The wide pH 
range that is from 2 to 12 is used for acid and base, which is to be used for hydrolysis 
purpose. For acid hydrolysis generally Hydrochloric acid (HCl) or Sulfuric acid 
(H2SO4) is used and for base hydrolysis Sodium or Potassium hydroxide is used. 
According to stability of molecule, the concentration of acid or base is decided. 
One can used more than one stress conditions to obtain desired degradation. If the 
desired degradation is not achieved at room temperature, then higher temperature 
is used. After the degradation process completed the degraded samples are neutral-
ized by same acid or base so as it can easily injected in HPLC column without any 
harm to silica stationary phase. For water insoluble samples alcoholic acid or base 
are used for obtaining degradation [9].
4.5 Oxidation
To carry out oxidation degradation of drug substance or drug product, generally 
hydrogen peroxide is used. Apart from hydrogen peroxide metal ions, oxygen and 
radical initiators can also be employed. The oxidizing agent, its quantity require-
ment, properties are depending on the drug substance under study. If hydrogen 
peroxide is used as a degradant, in that case combination of stress should not be 
employed. If elevated temperature is used in case of Hydrogen Peroxide, it leads to 
hydrolysis instead of oxidation because in Hydrogen Peroxide O-O are not stable 
and they may decompose at ambient temperature also. Due to heating, these bonds 
break faster and oxidation occurs. Sodium metabisulfite solution is used for neu-
tralization of oxidation degraded samples [9].
4.6 Heat
Active pharmaceutical ingredients, Dosage form with or without humidity can 
be undergoing thermal degradation. The sample is exposed to heat. (weather there is 
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humidity or absence of humidity as mentioned earlier) In case of liquid, humidity is 
completely avoided. While applying stress to liquid samples especially for injections, 
oral solutions, and syrups as further diluting the samples, the precaution should be 
taken because these types of samples may loss water and concentration of actual 
sample. By obtaining multiple time results, the detail information about primary 
and secondary degradation can collected. If any molecule is so stable that it cannot 
generate degradation, in such situation the energy analogous to the accelerated stress 
condition is to be applied to express efforts taken for obtaining degradation [9].
4.7 Photo stability
The exposure to light is one of the important degradation steps to obtain degra-
dation caused by light. This degradation is evaluated by obtaining any unacceptable 
change due to light. The recommendations related to photo stability are described in 
ICH guidelines Q1B.The UV–VIS light exposure with not less than 1.2 million hours 
to achieve degradation of sample. The samples are preferably exposed to cool white 
fluorescent light and near ultraviolet lamp. The natural light can be used, if specific 
instrument is not available, but there will be intensity problem as it is varying with 
time, weather conditions, pollution etc. due to which natural light becomes not 
suitable for degradation [9].
4.8 Evaluation of results
After generating forced degradation samples obtained by accelerated stress 
conditions, their evaluation is the important task. For evaluation purpose, each 
sample should be studied individually. The Chromatographic techniques includ-
ing High performance liquid chromatography (HPLC), Ultra-performance liquid 
chromatography (UPLC), UHPLC and Capillary Electrophoresis are commonly used 
techniques for this important task. The most important work is development and 
validation of stability-indicating method which can be able to separate every degra-
dation product from each other and from drug. Therefore, peak purity is important 
in sense of selectivity determinations of the method. One more important parameter 
is sensitivity, which can be helpful to asses’ impurities at lower level. There are 
chances that the impurity peak may get depressed at the time of method develop-
ment which is co-eluted. Many times, it may happen that two unknown impurity get 
merged due to which false results are appear for stability, therefore it is important to 
implement such analytical method that can have capacity to resolve each unknown 
impurity and that is helpful to control out of specification results [9] (Figure 2).
Figure 2. 
Important parameters and acceptance criteria for impurity profiling and stability indicating methods.
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5. Bioanalytical method development and validation
There were various regulatory agencies had done serious efforts to regulate 
bioanalytical method development and validation. Almost from last three decades 
there were large progresses in this area. The various regulatory agencies that were 
worked can be listed as US FDA, American association of pharmaceutical scien-
tists (AAPS), Health protection Branch HPB, Association of analytical chemists 
(AOAC), Center for Veterinary medicine (CVM), U. S. Department of Health and 
Human Services Food and drug Administration, Center for Drug Evaluation and 
Research (CDER), European Medicine Agency (EMA), China Food and Drug 
Administration (CFDA), European Bioanalytical forum (EBF), Global CRO Council 
(GCC), The Brazilian health regulatory agency (ANVISA, Brazil). To regulate 
and harmonize bioanalytical method development and validation first workshop 
was held in 3–5 December 1990, report of which was published in pharmaceutical 
research and in other journals. On basis of the reports of this workshop, the FDA 
was issued draft guidance on bioanalytical method development and validation in 
January 1999.The second FDA guidance was published in May 2001 on the basis of 
workshop which was held in January 2000.The recommendations for bioanalytical 
method development and validation for macromolecules was published in 2006. 
The recommendations for regulation and harmonization of bioanalytical methods 
were again refreshed in 2006. In 2010, a draft guidance was published by EMA for 
development and validation of bioanalytical methods. As per above discussion this 
can be concluded that there were serious efforts carried out to regulate bioanalytical 
method development and validation by the various abovementioned regulatory 
agencies.
6. Need of bioanalytical method development and validation
The various manufacturers are applying for Investigational new drug applica-
tion (IND), New drug application (NDA), Abbreviated new drug application 
(ANDA) to FDA. There was harmonization in this process related to human clinical 
pharmacology, bioavailability (BA) and Bioequivalence (BE), pharmacokinetic 
evaluation (PK), non-human pharmacology and toxicology studies and preclinical 
studies, which should be included in abovementioned applications. To obtain the 
data related to abovementioned requirements, there is need of development and 
validation of bioanalytical methods in biological matrices such as blood, serum, 
plasma or urine [10].
The most recent FDA guidance document on bioanalytical method development 
and validation was released in May 2018. Before this there was a guidance docu-
ments in 2001 and its revision in 2013 were released. The overall previous recom-
mendations remain same, only the following points are revised.
• The validation criteria for dilution and carryover
• There was clarification on the number of Quality control (QC) samples and 
replicates
• There will be no acceptance criteria for QCs for accuracy and precision
• The QCs should have to cover the sample concentration range
• The LLOQ should be evaluated for interference for each run
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• There will be the further acceptance criteria within the different batches
• The internal standard (IS) and the drift should be monitored
In this document following clarity regarding Ligand Binding Assay (LBA) 
was added
• The accuracy and precision runs
• The control of each sample should be included with clear definition
• The consistency in standard calibrator preparations
The significant change in final document, the incurred sample reanalysis sec-
tion was added which includes endogenous compounds, biomarkers, diagnostic 
kits, bridging data and dried blood spots [11]. The guidance documents (M10) on 
Bioanalytical Method Development and Validation was released by International 
Council for Harmonization of technical requirements for pharmaceuticals for 
Human Use (ICH), in February 2019. Simultaneously, American association of 
Pharmaceutical scientists (AAPS), European bioanalysis forum (EBF), Japan 
Bioanalysis forum (JBF), China Bioanalysis forum (CBF) were organized a 
workshop of industry, academia, and health authorities to discuss this draft guid-
ance. The objective of these discussions was the M10 guidelines which are for 
Bioanalytical Method Development and validation which are part of regulatory 
submissions. This guidance document explains the validation of Bioanalytical 
Methods form, which the concentration of analyte is determined from biological 
fluids. The concentration was obtained from pivotal nonclinical pharmacokinetic 
studies which are useful for taking the decisions over the regulatory submission 
including all phases of clinical trials [12].
6.1 Key principles of bioanalytical method validation and establishment
• Accuracy, precision, selectivity, sensitivity, reproducibility and stability are 
the fundamental parameters that ensure the acceptability of bioanalytical 
method.
• There should be specific protocol, study plan, report or SOP for bioanalytical 
method development and validation.
• How the analyte is being get affected by environmental, matrix, or procedural 
variables? Every step, including time of collection of matrix and overall inves-
tigation time, should be clarified.
• The physiological nature of samples gives variable matrix. When there are 
Liquid Chromatography-Mass spectrometry-Mass Spectrometry (LC-MS-MS) 
based procedures, then protocol should be designed to avoid matrix effect, 
matrix may change during method validation.
• It is necessary to validate bioanalytical method for the intended use or 
application.
• There should be written method validation report to claim the results.
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• The same biological matrix as the matrix in the intended samples should be 
used for validation purposes. It is necessary in case of limited availability of 
matrix like bone marrow.
• The stability at the time of matrix during collection and storage should be 
assessed before analysis.
• The stability of analyte in matrix from dosed subjects should be finalized in 
case of potentially labile metabolites.
• The parameters like accuracy, precision, reproducibility, response function, 
and selectivity of method for endogenous substances, metabolites, and known 
degradation products should be set for biological matrix.
• In case of selectivity the evidence should be produced that substance being 
quantified is the intended analyte.
• The concentration range of analyte should be defined on standard samples 
including their statistical parameter which clears the standard curve.
• To define concentration and response relationship an enough sample should 
be analyzed. This relationship should be continuous and reproducible. For this 
purpose, the standard used should be from dynamic range and nature of the 
concentration-response relationship. Generally, six to eight concentrations 
excluding blank can be used to define standard curve. In case of nonlinear 
concentrations more standard may be recommended.
• There should be proper demonstration to show the ability to dilute samples 
originally above the upper limit of the standard curve by accuracy and preci-
sion parameters in the validation.
• In case of high throughput analyses like multiplexing, multicolumn and paral-
lel systems, enough Quality control (QC) samples should be assessed to prove 
control of the assay. Based on the run size, the number of QC samples should 
be determined.
There should be proper placement of the QC samples in the run.
• There is a need to set a specific acceptance criterion for bioanalytical method 
to be considered as a valid method. That should be achieved for accuracy and 
precision for validation of QC samples over the range of standards.
6.2 Specific recommendations for bioanalytical method validation
• There should be minimum six standard points for matrix based standard curve 
excluding blank, which may be single or replicates and should cover the entire 
range of expected concentrations.
• Standard curve should explain the concentration-response relationship with 
appropriate weighting and statistical tests for goodness of fit.
• The Lower limit of quantitation, (LLOQ ) should be measured with accept-
able accuracy and precision which is the lowest concentration of the standard 
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curve. By using a least five samples independent of standards and its coef-
ficient of variation, the LLOQ can be established. The LLOQ should not 
be confused with the limit of detection and/or the low-Quality Control 
(QC) samples. The upper limit of quantification will be defined by highest 
standard.
• The accuracy and precision should be determined by using minimum of five 
determinations per concentration level excluding blank samples. The average 
value should be within ±15% of the theoretical value. The LLOQ should be 
up to ±20%. The coefficient of variance of precision should not exceed 15% 
and for LLOQ should not exceed 20%. The methods which give the results 
of accuracy and precision with these above-mentioned values should be 
acceptable.
• There should be proper demonstration of concentration of analyte in biologi-
cal matrix with which the accuracy and precision is determined. This can be 
performed by analyzing replicate sets of QC samples from same biological 
matrix. This QC sample should be representative of entire concentration range 
selected for standard curve. From which one concentration within LLOQ , one 
should be middle one that is middle QC (MQC) and last should be upper limit 
of standard curve that is High QC (HQC).
• All outliers should be included in reported method validation data and accu-
racy and precision data. The values of outliers that are determined statistically 
can also be reported with the calculations of accuracy and precision.
• The storage temperature stability in biological matrix should be determined for 
analyte. The freeze-thaw stability at minimum of three cycles of two concen-
trations in triplicates should be studied.
• The ambient temperature stability of analyte should be determined over the 
time period equal to typical sample preparation, sample handling and analyti-
cal run times.
• In case of instrument failure, reinjection reproducibility should be evaluated to 
determine an analytical run could be reanalyzed.
• For determination of specificity of assay method, a minimum of six concen-
tration of same matrix should be studied. In case of hyphenated techniques 
like mass-spectrometry based methods, it is not important to study six 
independent matrices. There should not any compromise to study matrix 
effect to ensure precision, selectivity and sensitivity in case of Liquid 
Chromatography-Mass spectrometry (LC-MS) and Liquid Chromatography-
Mass spectrometry-Mass Spectrometry (LC-MS-MS) based procedures. The 
selectivity should be evaluated throughout method development, method 
validation and it should be continued up to the application of method to 
actual study samples.
The acceptance/rejection criteria for spiked, matrix-based calibration standards 
and validation of QC samples should be based on theoretical concentration of 
analytes. For studying accuracy and precision, the specific criteria should be set in 
the standard concentration range [13] (Figure 3).
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7. Analytical techniques for method development and validation
The various analytical techniques are available for Qualitative and Quantitative 
analysis, which can be used in above explained types of analytical methods. The 
chromatographic techniques used as a separation tool and spectroscopic techniques 
are used for an identification and to obtain structural information. Among all these 
techniques High performance liquid chromatography, High performance thin layer 
chromatography, Spectrophotometric techniques and Hyphenated techniques are 
explained in brief.
7.1 High performance liquid chromatography
When we draw the attention towards the working principle of HPLC, which 
involves the injection of small sample (Generally in μl) into the stationary phase 
composed of 3–5-micron tiny particles. The injected components of the sample 
moved through the abovementioned stationary phase with the mobile phase which 
is forced through high pressure by the pump.
The HPLC technique is having advantage of High speed, Efficiency, Sensitivity 
and vastly superior over the simple liquid chromatography. The process of separa-
tion of components of sample involves chemical and physical interactions with the 
stationary phase particles. The separated components are detected at the end of 
column by the detector in the form of the liquid chromatogram (Figure 4).
The HPLC can be applied for separation of non-volatile compounds like Aspirin, 
Ibuprofen, Acetaminophen and then for separation of salts like Sodium Chloride, 
Potassium Phosphate. For the separation of proteins like Egg white and Blood 
Figure 3. 
Sequence showing development and validation of bioanalytical method.
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proteins. The HPLC can also be applied for separation of Organic Polymers, Heavy 
Hydrocarbons, Natural Products, Thermally unstable compounds and Enzymes [14].
For separation of many complex mixtures including biological samples high 
performance liquid chromatography is the best form of liquid chromatography 
(HPLC). HPLC is widely used for qualitative and quantitative analysis of differ-
ent types of pharmaceuticals due to its sensitivity. By using HPLC, one can obtain 
individual sample with its role in that sample. In 20th century, the HPLC methods 
were appeared for assay of bulk drugs and later become a principal method of 
Pharmacopeia. The interaction among the solute molecules and stationary phase, 
decides the mode of chromatography. HPLC is more versatile technique as vari-
ous modes are available. By using HPLC, the proper values of precision can obtain 
with excellent specificity of the methods. Though the specificity, precision and 
accuracy are obtained with HPLC methods, the system suitability parameters are 
first analyzed before analyzing these parameters. The more attention should also be 
providing for high accuracy, precision and specificity. By doing wide literature sur-
vey it was observed that HPLC is widely used technique among all chromatographic 
techniques. One of the reasons for this is detection system of HPLC which can able 
to detect every component of mixture. The UV detector is most widely used detec-
tor for HPLC. The Ultra-violet (UV) detector can analyze various wavelengths 
simultaneously by giving multiple wavelength programmers on HPLC software. 
Every component present in mixture which UV can detect that can be obtained 
by UV detector. A Photodiode array (PDA) detector is one of useful spectroscopic 
detector. By placing at the image plane of spectrophotometer various wavelength 
can be scanned simultaneously. For analysis of alcohols, sugars, carbohydrates, fatty 
acids and polymers, the refractive index detector is used as there is restriction for 
UV absorption of these compounds. The Refractive Index (RI) detector is one of the 
lowest sensitivity detectors but it can be applied for trace detection with low noise. 
For analyzing oxidizable and reducible substances, the electrochemical detector 
is implemented. In this detector the electrical output obtained by electron flow 
due to chemical reaction at electrode surface due to presence of above-mentioned 
compound is used for qualitative and quantitative analysis of these types of 
samples. Among various detectors available for HPLC, the most sensitive detector 
is fluorescence detector. The sensitivity of fluorescence detector is 10–1000 times 
more sensitive as compared with the UV detector. If sample contains any specific 
Figure 4. 
Flow diagram of working principle of HPLC.
Analytical Chemistry - Advancement, Perspectives and Applications
14
fluorescent compound, then it can be easily detected by this detector. For estimation 
of pharmaceuticals especially fluorescence detector is applied. As most of pharma-
ceuticals are polar in nature, there analyses are carried out as reverse phase HPLC. 
In recent years most of the researchers used reverse phase chromatography with UV 
detection, due to that the results are obtaining with best reliability, analysis, repeat-
ability and sensitivity. Generally, in pharmaceutical industry Octadecyl silyl (ODS) 
C18 is mostly used stationary phase. Many drugs can be easily obtained in pharma-
ceutical formulations and biological fluids by using HPLC. Nowadays, HPLC is one 
of the important tools for solving many problems in pharmaceutical industry. There 
are certain limitations to HPLC that high price of column, HPLC grade solvents and 
it is difficult to obtain long term reproducibility due to nature of column packings.
The Liquid Chromatography-Mass spectrometry (LC-MS) is wide choice for 
quality control and quality assurance in various stages in pharmaceutical industry. 
The LC-MS can be easily applied for assay of many drugs and pharmaceuticals also 
applied for analysis of impurities and degradation products. The most hyphenated 
technique like Liquid Chromatography-Mass spectrometry-Mass spectrometry 
(LC-MS-MS) is also available for above mentioned work [15].
7.2 High performance thin layer chromatography (HPTLC)
The advancement of Thin layer chromatography (TLC) is the HPTLC that 
is, High performance thin layer chromatography which an instrumental semi or 
automatic form of TLC. It is fast working, sensitive and can be able to analyze wide 
range of samples.
The HPTLC is advantageous to handle a sample with short analysis time for analy-
sis of even complex samples including crude drugs. As automation with the instrument 
it can be able to analyze entire chromatogram with many parameters without any 
interruption. The samples can be analyzed simultaneously or independently with 
standard that shows the reliability of technique. The HPTLC is equipped with high 
performance adsorbent layers having refined uniform particles, approx. 5 microns in 
diameter. All processes of experimentation including method development, optimi-
zation of various parameters and documentation are performed with standardized 
methods. The HPTLC can be applied for both qualitative and quantitative analysis of 
mixtures, as the technique is automated, the quantitative mode is more optimized as 
compared with the TLC. Also, it can be used for the assay of the compound (Figure 5).
The advantages of the HPTLC are as follows:
• Colored samples can be easily separated
• Many samples can be assessed easily on single plate which reduces the cost and 
time.
• Two-dimensional mode is possible
• Visualizing agent used which are Specific and Sensitive for detection purpose
• Other evaluation technique can be implemented for different samples with 
different light absorption characteristics.
• Radio labeled compounds can be monitored and microbial activity can be 
assessed.
• No regeneration and cleanup are required as the technique is disposable.
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Development of plate and evaluation of plate are separate processes therefore 
both can perform as per time available differently [15].
The important advantages of the HPTLC are fast, inexpensive method of analy-
sis. It can prove over high-performance liquid column chromatography when it is 
performed by skilled person for quantitative analysis. The qualitative and quantita-
tive analysis by the HPTLC with automated sample application and densitometric 
scanning shows very sensitive and reliable results. The HPTLC has important 
advantage of providing chromatographic fingerprints which can be stored as an 
electronic image [16].
7.3 UV-spectrophotometric methods
For the quantification of components present in solution, the UV absorption 
spectroscopy works on the principle of Beer-Lambert law [17] (Figure 6).
According to Beer-Lambert law,
 0A log I / I .c.l= = e  
where A = Absorbance.
I0 = intensity of incident light.
I = intensity of emergent light.
ɛ = molar absorptivity.
Figure 5. 
Diagram showing components of HPTLC.
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c = molar concentration of solute.
I = length of sample cell.
The natural Ultra-Violet (UV) absorption methods and chemical reactions 
spectrophotometric methods are having importance in pharmacopeia. In these 
methods quantitative data of reflection or transmission by the analyte as function 
of wavelength is measured. The method is based on the fact, that functional group 
of analyte absorbs UV radiation at specific wavelength in a solvent system. The 
λmax is the term used for maximum absorption of wavelength which is indepen-
dent of concentration. These methods require less time and less labor consumption. 
The method also gives best precision. The UV-Visible methods are applied for 
multicomponent analysis of samples [15].
7.4 Brief introduction of other spectroscopic techniques
The Near Infrared spectroscopy (NIRS) is one of the spectroscopic techniques 
that can be applied for multicomponent analysis of all types of samples and having 
advantage of non-destructive technique. For the purpose of raw material testing, 
quality control of finished product and to monitor the process, the NIR spectros-
copy plays important role in recent years. The great advantage of NIR is there no 
requirement of sample pre-treatment, the use of fiber optic probes and both the 
chemical and physical parameters can be obtained in single spectrum [15].
The Nuclear Magnetic Resonance (NMR) spectroscopy is one of the advanta-
geous techniques over UV and IR spectroscopy that it can detect the intermediate 
products like ions, reaction complexes, solvents of chemical reaction. The NMR 
spectroscopy provides unique information on the structure of intermediate due 
to which there is no need to restore various hypotheses to explain the mechanism 
of the process [18]. The mass spectrometry is one of the outstanding techniques 
in all type’s spectroscopies due to its sensitivity, detection limits and its wide 
range of application. It is widely applied in biochemical problems like proteome, 
metabolone, drug discovery and metabolism. This technique can also be applied 
for pollution control, food control, forensic science and natural product or process 
monitoring. It can also be applied in atomic physics, reaction physics, reaction 
kinetics, inorganic chemical analysis, ion-molecule reactions and determination of 
thermodynamic parameters [19].
7.5 Hyphenated techniques
Generally, for the qualitative and quantitative analysis of the samples, the 
separation technique is combined with the identification technique. In the analysis, 
Figure 6. 
Flow diagram of working principle of UV spectrophotometer.
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chromatographic and electrophoresis are used for separation or isolation of the 
required components. The quantitative determination or structural information 
of the sample under study is performed by spectrophotometry. The Hyphenated 
technique is nothing but the combination of both above said techniques that are 
separation and spectrophotometric technique. The various hyphenated techniques 
like Liquid chromatography-Mass spectrometry (LC-MS), Gas chromatography-
Mass spectrometry, Liquid Chromatography-Nuclear Magnetic resonance 
(LC-NMR), Liquid chromatography-Fourier transform infra-red spectroscopy 
(LC-FTIR), Capillary electrophoresis-Mass spectrometry (CE-MS) are used widely 
for qualitative and quantitative analysis. There may be a combination of more than 
one separation or detection technique like Liquid chromatography-Photodiode 
array-Mass spectrometry (LC-PDA-MS), Liquid chromatography-Mass spectrom-
etry-Mass spectrometry (LC-MS-MS), Liquid chromatography-Nuclear magnetic 
resonance-mass spectrometry (LC-NMR-MS), Liquid chromatography-photodiode 
array-nuclear magnetic resonance-Mass spectrometry (LC-PDA-NMR-MS) [20].
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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